• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最新进展:类风湿病的治疗

Update: treatment of rheumatoid disease.

作者信息

Hudson N P, Whisler R L

机构信息

Division of Immunology and Rheumatology, Ohio State University College of Medicine, Columbus.

出版信息

Compr Ther. 1988 Oct;14(10):51-6.

PMID:3053016
Abstract

The treatment of rheumatoid arthritis is, of necessity, highly individualized and thus invites the full application of the art of medicine. Patient education, physical therapy, NSAIDs, DMARDs, and surgical therapy all potentially play a role in the management of this syndrome. Careful and repeated assessment of signs and symptoms will identify patients who are likely to benefit from the wide array of helpful but imperfect drugs currently in use. The availability of increasingly effective therapy means that early referral and treatment are more important than ever in treatment of rheumatoid arthritis.

摘要

类风湿关节炎的治疗必然是高度个体化的,因此需要充分运用医学技艺。患者教育、物理治疗、非甾体抗炎药、改善病情抗风湿药及手术治疗在该综合征的管理中都可能发挥作用。对体征和症状进行仔细且反复的评估,将识别出可能从目前使用的众多虽有帮助但并不完美的药物中获益的患者。越来越有效的治疗方法的出现意味着,在类风湿关节炎的治疗中,早期转诊和治疗比以往任何时候都更为重要。

相似文献

1
Update: treatment of rheumatoid disease.最新进展:类风湿病的治疗
Compr Ther. 1988 Oct;14(10):51-6.
2
Office management of rheumatic disease. Pharmacology and laboratory evaluation.
Orthop Clin North Am. 1988 Oct;19(4):867-75.
3
Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia.风湿性疾病患者对非甾体抗炎药的偏好高于对乙酰氨基酚:一项针对1799名骨关节炎、类风湿关节炎和纤维肌痛患者的调查。
Arthritis Rheum. 2000 Feb;43(2):378-85. doi: 10.1002/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2.
4
Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.塞来昔布和罗非昔布在风湿性疾病中的临床概况。
J Hypertens Suppl. 2002 Sep;20(6):S25-30.
5
[The introduction of non-steroidal antirheumatics: is there a rational therapy].[非甾体类抗风湿药的引入:是否存在合理的治疗方法]
Schweiz Med Wochenschr. 1982 Aug 28;112(35):1200-8.
6
The role of anti-malarials in rheumatoid arthritis--the American experience.抗疟药在类风湿关节炎中的作用——美国的经验
Lupus. 1996 Jun;5 Suppl 1:S41-4.
7
Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines.类风湿关节炎药物治疗监测指南。美国风湿病学会临床指南特设委员会。
Arthritis Rheum. 1996 May;39(5):723-31.
8
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.类风湿关节炎的初始治疗应采取何种积极程度?与“非积极”改善病情抗风湿药治疗反应相关的因素及一项为期两年的开放标签试验的观点
Rheumatology (Oxford). 2004 May;43(5):619-25. doi: 10.1093/rheumatology/keh135. Epub 2004 Feb 24.
9
Diagnosis and management of rheumatoid arthritis.类风湿关节炎的诊断与管理
Am Fam Physician. 2005 Sep 15;72(6):1037-47.
10
Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.银屑病关节炎治疗:非甾体抗炎药和传统改善病情抗风湿药
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii74-7. doi: 10.1136/ard.2004.030783.